This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

ResMed Inc (RMD)

NYSE: Health Care

Company Income Statement
Jun 2014 Jun 2013 Jun 2012 Jun 2011
Sales 1.55B 1.51B 1.37B 1.24B
Cost of Sales 565.19M 505.66M 475.90M 441.35M
Gross Operating Profit 989.79M 1.01B 892.62M 801.80M
Selling, General, and Administrative Expenses 450.41M 430.80M 401.62M 372.25M
Research & Development 118.23M 144.89M 109.73M 92.01M
Operating Income before D & A (EBITDA) 421.15M 433.10M 381.26M 337.54M
Depreciation & Amortization 9.73M 78.28M 85.86M 70.62M
Interest Income 25.11M 38.87M 33.87M 26.04M
Other Income - Net 884.00K -2.19M 8.46M 10.74M
Special Income / Charges 0.00 0.00 -1.00M 0.00
Total Income Before Interest Expenses (EBIT) 431.08M 391.51M 336.73M 303.71M
Interest Expense 0.00 6.39M 4.79M 0.00
Pre-Tax Income 431.08M 385.12M 331.94M 303.71M
Income Taxes 85.80M 77.99M 77.10M 76.72M
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations 345.27M 307.13M 254.85M 226.99M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 345.27M 307.13M 254.85M 226.99M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 345.27M 307.13M 254.85M 226.99M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
351.60M 307.13M 255.85M 226.99M
Preferred Dividends
Net Income Available To Common 0.00 307.13M 254.85M 226.99M
Basic EPS from Continuing Ops. 2.44 2.15 1.75 1.49
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 2.44 2.15 1.75 1.49
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 2.44 2.15 1.75 1.49
Basic Normalized Net Income/Share 2.49 2.15 1.75 1.49
EPS fr Continuing Ops. 2.39 2.10 1.71 1.44
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 2.39 2.10 1.71 1.44
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 2.39 2.10 1.71 1.44
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
2.44 2.10 1.71 1.44
Dividends Paid per Share 1.00 0.68 0.00 0.00
RMD News

Analysts Ratings for RMD

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 5 4 4 5
Moderate Buy 0 0 0 0
Hold 4 5 5 6
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 0
GET RMD ANALYST REPORT

Brokerage Partners

RMD Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs